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Members of the six-transmembrane segment family of ion channels share a common structural design.
However, there are sequence differences between themembers that confer distinct biophysical properties on
individual channels. Currently, we do not have 3D structures for all members of the family to help explain
the molecular basis for the differences in their biophysical properties and pharmacology. This is due to
low-level expression of many members in native or heterologous systems. One exception is rat Kv1.2 which
has been overexpressed in Pichia pastoris and crystallised. Here, we tested chimaeras of rat Kv1.2 with the
hERG channel for function in Xenopus oocytes and for overexpression in Pichia. Chimaera containing the
S1–S6 transmembrane region of HERG showed functional and pharmacological properties similar to hERG
and could be overexpressed and purified fromPichia. Our results demonstrate that rat Kv1.2 could serve as a
surrogate to express difficult-to-overexpress members of the six-transmembrane segment channel family.
I
on channels represent a major family of membrane proteins, each evolved to perform a specific, often unique,
physiological task1. Knowledge of high resolution structure for eachmember of the family would not only help
understand the molecular basis for their unique function, but would facilitate structure-guided drug develop-
ment. Although in recent years, there have been significant breakthroughs in the structural biology of ion
channels2–4, structures are available only for a handful of channels and the majority of these structures are not
for human proteins. The reason for the frustratingly slow progress is that these channels occur in low abundance
and many of them are difficult to over-express in heterologous systems in quantities suitable for X-ray crystal-
lographic studies.
One potential approach to circumvent this problem is to generate chimaeric constructs between a channel (we
name this ‘host’) that has been successfully over-expressed and crystallised and the desired target channel (we
name this ‘guest’). An ideal chimaera would include parts of the host channel that enable over-expression of
functionally important and ‘druggable’ regions of the ‘guest’ channel. Such approaches are already yielding
structural information on key functional elements of several ion channels5,6, although they are not of human
in origin.
A major subfamily of ion channels is the six-transmembrane (6-TM) segment channels. They are tetramers,
each subunit comprising 6 membrane spanning domains with cytoplasmic N- and C-termini. With over 140
members, the family comprises voltage-gated potassium (Kv) channels, cyclic nucleotide gated (CNG) channels,
hyperpolarisation activated (HCN) channels and TRP (transient receptor potential) channels1. They contribute
to a wide range of important physiological roles in the body, including neuronal excitability, muscle contraction,
regulation of hormone secretion, vascular tone and several specialised functions1. As such, they are being
increasingly recognised as novel drug targets for a variety of diseases. The fact that they all share a common
membrane topology, and presumably follow a similar folding paradigm, allows design of functional chimaeras
between a member whose structure has been solved and a member whose structure is important to solve.
Here we chose the rat Kv1.2 channel as a ‘host’ because it is closer to human channels than bacterial channels,
has been over-expressed in Pichia pastoris7 and subsequently crystallised to produce a high resolution structure8.
We chose the ether-a-go-go related (hERG) potassium channel as ‘guest’ because this is one of the most sought-
after ion channels when it comes to structure. It is of interest to channel biologists because it displays unique
biophysical properties and plays a crucial role in cardiac rhythm2–4, and to the pharmaceutical industry because it
presents a significant hurdle in the way of production of safe drugs (see later9).
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hERG, encoded by KCNH2, contributes to the IKr current which
helps to repolarise the cardiac action potential and maintain the
cardiac rhythm2–4. If its function is compromised, either due to an
inherited genetic mutation, or drug blockade, the result is prolonga-
tion of the cardiac action potential, a condition described as the
Long-QT syndrome (LQTS), which in turn could lead to cardiac
arrhythmias and even sudden death2–4. hERG mediated sudden
death as a side effect of non-antiarrhthmic drugs has been receiving
increased attention by the regulatory bodies2–4,9.
As mentioned above, hERG exhibits unusual biophysical prop-
erties. When the cardiac cell membrane is depolarised, it is activated
(opening of activation gates) slowly, but undergoes rapid C-type
inactivation (closure of inactivation gates). This property allows
the channel to remain in a closed state during depolarisation and
thereby sustain the plataeau phase of the cardiac action potential2,3.
As the cardiac action potential begins to hyperpolarise (due to activa-
tion of IKs), the inactivation gate opens rapidly (recovery from inac-
tivation) but the activation gate closes (deactivation) slowly. This
allows K1 efflux and rapid repolarisation of the action potential.
These properties are the reason why hERG displays inward rectifica-
tion- a property unique to hERG2–4.
hERG is blocked promiscuously by a variety of structurally unre-
lated drugs. This has led to the withdrawal of several blockbuster
drugs (e.g. Tefenadine) from the market and to mandatory (FDA
requirement) screening of all new drugs for hERG blockade prior to
clinical trials. Consequently, it has been recognised that drugs should
be screened for hERG blockade prior to clinical trials3,9.
hERG belongs to Kv channel subfamily. Its S1–S4 segments form
the voltage sensing domain (VSD) and the S5–S6 together with the P-
loop form the pore domain (PD). VSD contains positively charged
residues (Arg/Lys) in S4 and three conserved negative charges (Asp/
Glu) in S2–S32–4,10. In addition, hERG contains three additional nega-
tive charges. During depolarisation, S4moves out of the electric field,
leading to the opening of activation gates located at the cytoplasmic
end of the pore2–4,10–13. The C-type inactivation gate is at the extra-
cellular end of the pore2–4,14. The N-terminal PAS domain and the
C-terminal cyclic nucleotide binding domain (cNBD) accelerate
deactivation kinetics2–4,15–18.
The aim of the study was to generate a Kv1.2-hERG chimaera that
not only retains the unique biophysical and drug binding properties
of the hERG channel, but could be overexpressed in Pichia in mil-
ligram quantities to facilitate structural studies.
Results
Generation of a functional Kv1.2-hERG chimaera. Despite
significant progress in our understanding of the structure-function
relationships of hERG2–4 and recent breakthroughs in the structural
biology of Kv channels6,8, our knowledge is still inadequate to allow in
silico design of chimaeric channels that are certain to give rise to
functional channels. Likewise, we do not know which regions of
Kv1.2 are essential to drive high level expression in Pichia, while
supporting the function of the substituted domains. For this
reason, we have taken an empirical approach and generated three
chimaeras by substituting different functional domains of hERG into
Kv1.2 in the hope that one ormore of these chimaeras would give rise
to functional channels and can be over-expressed in Pichia. In
designing the chimaeras, we were guided by the Kv1.2-hERG
sequence alignment (Fig. 1), generated on the basis of the studies
of Kv1.28 and KvAP19,20, and mutagenic studies on the functional
regions of hERG10,11,21. The chimaeras were named P-S6, S4/S5–S6,
and S1–S6; the names correspond to the regions of hERG substituted
into Kv1.2 (Fig. 2a). P-S6 harbours the selectivity filter, drug binding
sites and the S6 channel gate. S4/S5–S6 has additional domains that
couple the voltage sensor to pore gating. The third chimaera, S1–S6
has the entire transmembrane portion of hERG. This would be an
ideal construct because if functional, its structure would explain what
makes hERG unique in terms of both its biophysical and drug
binding properties.
To test the function, we expressed the chimaeric constructs in
Xenopus oocytes and measured currents using the two-electrode
voltage clamp technique (Fig. 2b). Currents were elicited by a series
of depolarising pulses, delivered at 10 mV intervals, to 140 mV
from a holding potential of 280 mV, followed by repolarisation to
250 mV (hERG). Both P-S6 and S4/S5–S6 constructs failed to show
currents either during the depolarising steps or subsequent repolar-
isation (Fig. 2b). By contrast, S1–S6 displayed currents that were
comparable to hERG (Fig. 2b,d). Like hERG, the S1–S6 chimaera
activated slowly at potentials positive of 250 mV; current ampli-
tudes increased with voltage (voltage dependent activation), but at
more positive voltages, the amplitudes declined due to inactivation
(Fig. 2b,d). The current amplitudes of the chimaera, however, were
consistently smaller (,3-fold) than those of hERG for an equivalent
amount of injected cRNA.
Comparison of voltage dependence of activation of the S1–S6
chimaera with hERG. The voltage dependent properties of the
chimaera are markedly similar to those of hERG (Fig. 2d–e). When
currents (I) at the end of each test pulse (steady-state currents) were
plotted against the voltage (V) applied, a bell-shaped relationship
was apparent for both hERG and the chimaera (Fig. 2d); the
decline in current amplitude at positive potentials is due to
inactivation, a feature unique to hERG. Furthermore, the chimaera
passed significant current (tail current) during the 250 mV
repolarising voltage step (Fig. 2b,e,f), indicating slow closure
(deactivation, coupled with rapid recovery from inactivation- see
later) of the chimaeric channel. This again is a hallmark feature of
hERG. In Fig. 2e, peak tail currents (at250 mV)were plotted against
the preceding voltage pulse using the Boltzmann function to obtain
biophysical parameters that determine the voltage dependence of
channel activation. Activation of the chimaeric channel occurred at
potentials positive of 250 mV, similar to the hERG channel. The
V1/2 (voltage for half-maximal activation) value (210.78 6
3.55 mV) is not significantly different (P . 0.05) from that of
hERG (218.03 6 0.9 mV). The voltage dependence of channel
activation (slope factor, k 5 12.94 6 1.66 mV) of the chimaera,
however, is significantly greater (P , 0.05) than that of hERG
(k 5 6.99 6 0.22 mV).
Taken together, these results suggest that substitution of S1–S6 of
hERG confers on Kv1.2 the key biophysical properties of the hERG
channel, including slow activation, strong voltage dependent inac-
tivation and slow deactivation. The minor differences in biophysical
parameters are expected because the chimaera lacks the cytosolic
domains of hERG, which are known to modulate the biophysical
properties conferred by the transmembrane domain2–4,15–17,22,23.
Comparison of activation and deactivation properties of the S1–
S6 chimaera with hERG.The time-course of activation for the S1–S6
chimaera at various membrane potentials, is compared with the
superimposed hERG activation curves in Fig. 3a (chimaera: grey
traces; hERG: black traces). The results indicate that the rate of
activation of hERG and the chimaera is voltage dependent; the
activation curves could be described with fast and slow activation
time constants. However, the activation kinetics of the chimaera,
both fast and slow, are significantly faster than that of the hERG
channel at all potentials between 240 mV and 20 mV (Fig. 3b,c).
These results indicate that the cytosolic domains of hERG play a role
in the slow activation of hERG. Interestingly, such faster kinetics
were described for erg1-sm, a smooth muscle isoform of hERG,
which lacks the C-terminal 101 amino acids, but is otherwise very
similar to the cardiac isoform24.
Besides faster activation kinetics, the chimaera displayed large
transient currents at potentials positive to 0 mV, the amplitude of
which increased with the increase in depolarisation. Although hERG
www.nature.com/scientificreports
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current traces show occasional transients, they are considerably
smaller, being detectable only at strong depolarising potentials
($30 mV). In this respect, again, the chimaera is similar to erg1-
smwhich showed large transient currents24. Such large transients are
also a characteristic feature of ELK channels25, which are closely
related to hERG.
Deactivation kinetics were determined from current traces
recorded at various repolarisation potentials (2120 to 150 mV)
following a strong depolarising pulse (140 mV; Fig. 4a). Fig. 4b
shows representative deactivation current traces during repolarisa-
tion for hERG and the S1–S6 chimaera. The traces could be described
with slow and fast components, from which time constants for deac-
tivation were calculated for each voltage. Fig. 4c–d shows plots of
repolarising voltage against fast and slow deactivation time con-
stants. The results show that deactivation kinetics of the S1–S6 chi-
maera for the fast component are significantly faster than those of
hERG. At 290 mV, for example, the mean tfast (time constant for
fast deactivation) for the chimaera was 24.5 6 8.1 ms, and that for
hERG was 96.4 6 18.0 ms. Time constants (tslow) for the slow
(minor) component of deactivation showed no significant difference
between hERG and the chimaera in the voltage region (2120 to
260 mV) where they could be reliably determined. In this respect,
the chimaera again shows similarity to erg1-sm, which deactivates
about four fold faster than hERG24.
Comparison of inward rectification properties of the S1–S6
chimaera with hERG. hERG is unique among Kv channels in that
it shows inward rectification. The mechanism of inward rectification
in hERG, however, is mechanistically different from that of inwardly
rectifying potassium (Kir) channel family2–4. In hERG, inward recti-
fication is brought about by fast inactivation at depolarising poten-
tials followed by the rapid recovery from inactivation, coupled with
slow deactivation, at hyperpolarised potentials. Fig. 4e shows a plot of
peak current amplitudes during the repolarising pulses against
voltage for hERG and the S1–S6 chimaera (protocol Fig. 4a). Both
hERG and the chimaera display bell-shaped I-V relationships, with
reversal potentials (,290 mV) expected for a potassium selective
channel. However, there is a rightward shift for peak current
amplitudes by ,20 mV (from 240 mV for hERG to 220 mV for
the chimaera). This shift appears to result from a positive shift in
activation (Fig. 2e) and even greater shift in inactivation (Fig. 5c, see
later).
Comparison of inactivation properties of the S1–S6 chimaera with
hERG. A standard three pulse protocol was used to determine the
voltage dependence of inactivation/channel availability (Fig. 5a). A
1 s pulse to 135 mV was first applied in order to attain steady state
inactivation. This was followed by a series of test pulses to potentials
ranging from 2145 to 135 mV for 20 ms which is long enough to
Figure 1 | Sequence alignment of Kv1.2 and hERG showing sites of substitutions. Potential transmembrane regions (highlighted in yellow) and other
functional elements (S4–S5 linker and pore-helix) are labelled. Arrows indicate sites where different chimaeras were joined: Black, S1–S6;
red, S4/S5–S6; blue, P-S6.
www.nature.com/scientificreports
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allow recovery of channels from inactivation, but too short to allow
deactivation. The third pulse to 135 mVwas to measure the relative
number of channels that have recovered from inactivation during the
preceding second pulse. Fig. 5b shows representative currents from
the protocol, alongside currents recorded during the third pulse.
Although both the chimaera and hERG show currents recovered
from inactivation, there are striking differences between the two.
As demonstrated previously26, hERG displays instantaneous
currents at the start of the third pulse; these currents represent
channels that have fully recovered from inactivation, but failed to
undergo deactivation during the preceding test pulse. Like hERG, the
chimaera also showed currents from channels that have recovered
from inactivation; the kinetic profile of these currents, however, is
different from that of hERG. The kinetics of recovered chimaeric
channel currents are markedly dependent on the potential in the
preceding test pulse; the more negative the voltage of the preceding
pulse was, the slower were the kinetics. The time required to reach
peak currents (IMax) as a function of preceding test voltage is depicted
in Fig. 5d. One possible explanation for this result is that where the
test pulse potentials are very negative, some of the channels might
not only have recovered from inactivation, but have undergone
deactivation. During the third pulse, such channels would be
activated slowly resulting in a slow onset of currents. Thus whereas
with hERG, currents during the third pulse representmostly currents
that have recovered from inactivation, with the chimaera, the
currents are due to recovery from inactivation as well as from
activation of deactivated channels. The more negative the test
potential is, the greater would be the population of deactivated
channels. Such explanation is consistent with the faster
deactivation kinetics of the chimaera relative to hERG (Fig. 4). An
alternative explanation is that the channel goes through several
closed states before opening, the population of which is voltage
Figure 2 | Functional analysis of hERG-Kv1.2 chimaeras. (a) Schematic of constructs showing hERG segments (gray) substituted into Kv1.2 (black and
white) (b) Representative current families recorded from oocytes injected with cRNA corresponding to the constructs in (a). Currents for the chimaeric
channels were recorded using the hERG voltage step protocol (280 mV to140 mV in 10 mV intervals, followed by a step to250 mV; interpulse interval
was 20 s). Currents through KV1.2 were recorded at various step potentials (280 mV to 180 mV) delivered in 10 mV increments from a holding
potential of 280 mV; interpulse interval was 10 s. Current traces for hERG and the S1–S6 chimaera are shown in colour (hERG: 280 to 0 mV, blue;
110 mV, green; 120 to 140 mV, red; and S1–S6 chimaera: 280 to 210 mV, blue; 0 mV, green; 110 to 140 mV, red). Also shown is the scaled version
of tail currents for the S1–S6 chimaera. (c) Schematic of the protocol used to record currents through hERG and the chimaeras. (d) Plots of voltage against
steady-state currents (mean 6 SEM) recorded at the time point indicated by a black arrow in C. * indicates currents through hERG are significantly
greater than the S1–S6 chimaera (p, 0.05). (e) Plots of voltage against peak tail currents (mean 6 SEM) recorded at the beginning of the 250 mV pulse
(corresponding to gray arrow in c). The lines joining the mean currents represent Boltzmann distribution. The V1/2 value of the S1–S6 chimaera (210.78
6 3.55 mV, n5 13) is not significantly different (p. 0.05) from that of hERG (218.03 6 0.90 mV, n 5 20). However, slope (k) values are significantly
different (p , 0.05) between hERG (6.99 6 0.22, n 5 20) and the S1–S6 chimaera (12.94 6 1.66, n 513). (f) Normalised plot of data from (e).
www.nature.com/scientificreports
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dependent. Such properties results in Cole-Moore shift (where the
rate of activation depends on the preconditioning pulse), which is
exhibited by the eag channels (KCNH1) that are closely related to
hERG27.
Peak currents elicited at the beginning of the third pulse were
plotted as a function of the variable voltage of the second pulse using
the Boltzmann function. The results (Fig. 5c) show a large positive
shift in voltage required for recovery from inactivation of the chi-
maera (217.096 2.37 mV for chimaera, compared to hERG260.47
6 6.20 mV). A similar positive shift in inactivation has been re-
ported for erg1-sm24.
Comparison of dofetilide binding properties of the S1–S6 chi-
maera with hERG. Dofetilide, a class III anti-arrhythmic drug is a
potent blocker of hERG and is widely used to distinguish hERG
currents from other currents9,28. For this a three step voltage
protocol as outlined in Fig. 6a was used. Application of 10 mM
dofetilide for 10 min caused complete inhibition of both the
chimaera and the hERG channel (Fig. 6b–d). To examine if there
is any difference in the affinity of the drug between the chimaera and
hERG, effect of increasing concentrations of the drug on current
inhibition was determined. The results (Fig. 6d) show that there is
no significant difference (p. 0.05) in the IC50 (drug concentration at
which 50% of the channels are blocked) values between the chimaera
(39.54 6 8.68 nM) and the hERG channel (19.32 6 9.6 nM).
Overexpression of hERG in Pichia. Having demonstrated that the
chimaeric channel exhibits the key functional and pharmacological
properties of the channel, we next set out to express the chimaeric
channel in Pichia pastoris (it may be noted that we were unable to
express hERG in Pichia). For this we cloned the cDNA encoding the
His-tagged S1–S6 chimaera into the pPIC3.5 Pichia expression
vector and used the resultant construct to transform the KM71
strain of Pichia pastoris. To compare the levels of expression, we
have also transformed the cells with pPIC3.5-Kv1.2 (Kv1.2 is also
His-tagged). Cultures of the transformed cells were treated with
methanol to induce the expression of the channels and cells
pelleted from 1 ml culture (at a density of O.D. 8.0) were
extracted into 200 ml of SDS sample buffer and serial dilutions of
the extracts were subjected to western blotting using anti-His
antibodies (Fig. 7a). Two bands, corresponding to ,70 KDa and
,60 KDa, were seen in the diluted lanes, which may correspond
to fully- and core -glycosylated proteins. Presence of bands at
15512 and 151024 diluted samples with comparable intensities
demonstrates that the expression level of the chimaera may be
comparable to that of Kv1.2.
We next attempted to purify the S1–S6 chimaera by affinity
chromatography using the cobalt resin. Fig. 7b shows Coomassie
gel (10% SDS-PAGE) staining of proteins obtained during frac-
tionation of the detergent solubilised membranes (45 mg of mem-
brane protein). A major band around 70 KDa was seen with some
low molecular weight bands in lanes eluted with 500 mM imida-
zole. The minor bands could include breakdown products of the
chimaera, as can be seen in the western blot of corresponding
fractions, where the major band is in the region of 70 kDa
(Fig. 7c).
Figure 3 | Comparison of the activation kinetics of hERG and the S1–S6 chimaera. (a) Comparison of representative channel activation current traces
between hERG (black traces) and the S1–S6 (grey traces) chimaeras at the indicated voltage steps. (b–c) Comparison of the voltage dependence of fast
(b) and slow (c) activation time constants calculated from the activation current traces, as described in methods (chimaera, n 5 8; hERG, n 5 5).
The fast as well as slow activation kinetics of the S1–S6 chimaera are significantly faster than those for hERG (p , 0.05) at all potentials examined.
www.nature.com/scientificreports
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Discussion
Rat Kv1.2 is the only member of the eukaryotic 6-TM mammalian
channels whose structure could be determined by X-ray diffrac-
tion8. Progress in the determination of other members of this
family is hampered largely by the inability to overexpress these
channels in amounts sufficient to generate crystals. The reasons
why some proteins can be overexpressed, but others are poorly
expressed in heterologous systems are not known, although one
contributing factor that has been shown to determine protein
expression is the N-terminus29. Furthermore, smaller proteins
can be expressed relatively more easily than large complex pro-
teins. For these reasons, we postulated that the N-terminus of rat
Kv1.2 could be used to support overexpression of the transmem-
brane domains of other 6-TM channels. A key requirement,
however, is that the chimaeras are functional and display the
properties of the substituted domain. It is well known that the
majority of the functional properties in 6-TM channels are assoc-
iated with their transmembrane domains. Furthermore, it is gen-
erally assumed that folding of these domains is conserved despite
the differences in their amino acid sequences. Thus we hoped to
generate chimaeras that could not only be overexpressed but are
functional. To test our hypothesis, we chose hERG as a candidate
‘guest’ channel because its sequence is significantly different from
that of Kv1.2 (,90% different in the transmembrane portion)15–17
and exhibits unusual functional properties and pharmacology. In
particular, it is promiscuously blocked by structurally diverse
drugs- which is a common reason for removal of drugs from
the market and for failure of drugs to enter clinical trials3,9.
Figure 4 | Comparison of the deactivation kinetics of hERG and the S1–S6 chimaera. (a) Voltage protocol used to measure deactivation kinetics. (b)
Representative deactivation current traces of hERG and the S1–S6 chimaera at various voltage potentials following the140 mV pulse. (c–d) Comparison
of the voltage dependence of fast (b) and slow (c) deactivation time constants calculated from deactivation current traces, as described in methods
(chimaera, n 5 8; hERG, n5 5). The fast deactivation kinetics of the S1–S6 chimaera are significantly faster than those for hERG (p , 0.05).
(e) Normalised current-voltage relationships of peak fully activated currents (n 5 7). Erev values were calculated by fitting the linear section of the curve
and calculating the x-intercept (not shown). Erev values were <290 mV.
www.nature.com/scientificreports
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Here, we report successful generation of a Kv1.2 chimaera that
contained the S1–S6 transmembrane portion of hERG. It not only
exhibited the functional and pharmacological properties of hERG,
but could be overexpressed in Pichia pastoris. Co-incidentally, the
study also provided important insights into the structure-activity
relationships of hERG.
The other two chimaeras, S4/S5–S6 and P-S6, were not functional
when expressed in Xenopus oocytes. Swartz and colleagues have
reported extensive studies on chimaeras in which they substituted
segments of KvAP30, or TRP channels (TRPM8 and TRPV1)31 into
Kv2.1. Of the many chimaeras they studied, three of their pore chi-
maeras between Kv2.1 and KvAP (C3(S5–S6)AP, C7(S5–S6)AP and
C11(S5–S6)AP) are comparable to our S4/S5–S6 chimaera (see
Supplementary figure 1 in Alabi et al30). Their data showed that
substitution of residues beyond the S6 helix results in loss of function.
Our S4/S5–S6 chimaera also had a substitution beyond the S6 helix.
Although this may seem consistent with their results, the same sub-
stitution in our S1–S6 chimaera had no effect on function. Thus the
reasons for lack of function for the S4/S5–S6 chimaera remain
unclear. The study by Alabi et al did not include chimaeras compar-
able to our P-S6.
The S1–S6 chimaera harbours the major functional domains
of hERG: the pore, the voltage sensor, activation and inactiva-
tion gates and drug binding pocket. All properties attributed to
these domains were largely borne by the chimaera, including
slow activation (Figs. 2–3), slow deactivation (Fig. 4), fast inac-
tivation (Figs. 2, 5), strong inward rectification (Fig. 4) and
inhibition by the class III anti-arrhythmic drug, dofetilide
(Fig. 6). However, there are interesting differences in the para-
meters that govern the biophysical properties of the hERG chan-
nel: (i) the activation and deactivation kinetics of the chimaera
are relatively faster than hERG, (ii) the chimaera showed fast
(large) transient currents, the amplitude of which increased with
depolarisation, and (iii) the amplitudes of currents elicited dur-
ing repolarisation (tail currents) are much smaller than hERG.
Intriguingly, much of the biophysical behaviour of the channel is
rather more similar to erg1-sm, a smooth muscle isoform of
hERG24 than to hERG.
Figure 5 | Comparison of recovery from inactivation of hERG and the S1–S6 chimaera. (a) The three stage voltage protocol used to measure recovery
from inactivation. Voltage was first stepped from 280 mV to 1 35 mV to fully inactivate the channels, then stepped from 2145 to 135 mV, in 10 mV
increments, followed by a third 135 mV step, and then a final 2145 mV step to relieve inactivation. (b) Representative current traces for hERG and the
chimaera using the protocol shown in (a). The scaled-up traces show currents during the third 135 mV step; they represent the currents recovered from
inactivation during the preceding voltage steps. (c) Voltage-dependence of the recovery from steady-state inactivation. The normalised peak recovered
currents were plotted against voltage and fitted with a Boltzmann function. There was a significant (p, 0.05,) rightward shift in the V1/2 value of<40 mV
for the S1–S6 chimaera (217.09 6 2.37, n 5 12) compared to hERG (260.47 6 6.20 mV). (d) Voltage dependence of the time to reach peak current
(IMax); the S1–S6 chimaera takes significantly (p , 0.05) longer time compared with hERG to reach peak current over the voltage range examined.
www.nature.com/scientificreports
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Many of the differences between erg1-sm and hERG have been
attributed to a single position in the S4 segment. hERG has a valine at
535, whereas erg1-sm has an alanine at the equivalent position,
A53724. Mutation of alanine to valine (A537V) in erg1-sm converted
many of its biophysical properties to become similar to those for
hERG, including the loss of transients, larger outward tail currents
upon repolarisation and slow activation. Conversely, when valine in
hERG was mutated to alanine, the resulting mutant, V535A, dis-
played transient currents, smaller tail currents and faster deactiva-
tion kinetics. In fact, properties of the V535A hERGmutant channel
seem very similar to that of our S1–S6 chimaera, although our S1–S6
chimaera has valine at position 535. It has been reported that rat erg3,
a neuronal isoform of erg, exhibits properties similar to erg1-sm24;
however, it has a valine at position 537. Collectively, these results
suggest that the S4 residue alone (valine vs alanine) does not deter-
mine the differences between hERG and erg1-sm and that cytosolic
domains play a role. The fact that the S4 positions in hERG are likely
accessible to the cytosolic domains10 supports such possibility.
The N- and C-termini of hERG, as well as of other isoforms of erg,
bear the PAS and cNBD domains respectively2–4,15,16. These domains
are thought to influence both deactivation and inactivation kinetics
of hERG. A role for C-terminus in activation, roles for both N-
and C-termini in deactivation and inactivation have been re-
ported2–4,32.The Kv1.2 cytosolic domains appended to the S1–S6
chimaera lacks these domains, yet the chimaera exhibits slow kinetics
of activation and deactivation, fast inactivation and inward rectifica-
tion, although they are somewhat attenuated when compared with
hERG. These results suggest that the transmembrane portion of
hERG is largely responsible for all the unique biophysical properties
of the channel and that the cytosolic domains have amodulatory role.
In contrast to hERG, to recover from inactivation the chimaera
does not require strong hyperpolarised potentials (V1/2 for recovery
from steady-state inactivation is ,40 mV positive when compared
with hERG) (Fig. 5). This differencemay explain the transient activa-
tion currents as well as the profile of currents during the final step in
the 3-step protocol used to study the steady-state inactivation
(Fig. 5). Slower rate of inactivation was suggested as the cause of
transients in erg333. During the final step of the steady-state inactiva-
tion measurements, the chimaera showed currents that were remin-
iscent of the Cole-Moore shift reported in eag channels, where
residues 7–12 (RRGLVA) of the N-terminus are thought to contrib-
ute to this phenomenon34. This sequence is absent in the correspond-
ing region of Kv1.2. Thus the origin of the Cole-Moore shift in the
chimaera remains unclear, but is likely associated with the trans-
membrane portion of hERG. One possible, albeit simplistic, biophys-
ical explanation for the Cole-Moore like shift seen with the chimaera
is as follows (Supplementary Figure 1): During the first depolarising
pulse (see Fig. 5a), the channels open (O) from the closed state (C)
Figure 6 | The S1–S6 chimaera is inhibited by dofetilide, the classical
hERG pore blocker. (a) A three step voltage protocol used to determine
inhibition by dofetilide. (b–c) Representative current traces for hERG (b)
and the S1–S6 chimaera (c) before (black trace) and during (light gray
trace) application of 10 mMdofetilide and after washout of the drug (dark
gray). (d) Dofetilide concentration-response relationship for hERG and
the S1–S6 chimaera. IC50 value for inhibition by dofetilide for the S1–S6
chimaera (39.54 6 8.68 nM) was not significantly different from that for
hERG (19.32 6 9.6 nM) (p . 0.05; n 5 4).
Figure 7 | Expression and purification of the S1–S6 channel protein in
Pichia pastoris. (a) Western blots of Kv1.2 and the S1–S6 chimaera.
Methanol induced cells pelleted from 1 ml culture (at a density of O.D.
8.0) were extracted into 200 ml of SDS sample buffer using glass beads and
serial dilutions of the extract were subjected to western blotting using anti-
His antibodies (b) Purification of the S1–S6 chimaera by Talon metal
affinity chromatography. 45 mg of solubilised membrane proteins (input)
were subjected to purification as described in methods. E1–E7 represent
fractions eluted with 500 mM imidazole. 5 ml of each fraction were
subjected to SDS-PAGE and Coomassie blue staining. (c)Western blotting
of diluted fractions from the affinity purification. The input (lane 1) and
flowthrough were loaded at a dilution of 1550, whilst all the other samples
were loaded at 1510 dilution.
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and undergo inactivation (I) (C R O R I); during the following
second hyperpolarising pulse, the channels recover from inactivation
(I R O), but a significant proportion of the open channels also
undergo deactivation (I R O R C); during the third depolarising
test pulse, open channels are expected to elicit instantaneous outward
currents, but the closed channels open slowly (CR O) due to slow
activation kinetics. The net result of these events would be appear-
ance of currents that resemble the Cole-Moore shift. In the case of
hERG, deactivation is relatively slow; thus the occurrence of IROR
C transition during the second pulse is expected to be limited; for this
reason, hERG shows mostly instantaneous currents.
There is very little sequence similarity between the cytosolic
domains of hERG and Kv1.2. The sequence homology within the
transmembrane regions of the two proteins, likewise, is also low,
compared to other members of the Kv channels2. Thus the fact that
we were able to generate functional chimaeras of Kv1.2 that repro-
duced almost all properties of hERG is highly significant because it
suggests that the transmembrane portion of hERG and cytosolic
domains of Kv1.2 could fold into independent functional domains,
and folding and function are not dependent on each other. This
observation suggests that the approach could be used as a general
strategy to generate functional chimaeric channels with other 6-TM
channels, including those that are distantly related to Kv1.2.
The S1–S6 chimaera showed expression levels that were compar-
able to those of rat Kv.2 when examined by western blotting of the
extracts of induced Pichia cells diluted serially (Fig. 7). Western
blotting of the purified fraction showed two bands that presumably
correspond to the core and glycosylated versions of the protein. The
chimaera showed double bands of similar size when expressed in
HEK293 cells and showed clear expression at the plasma membrane,
indicating that the chimaera likely attains native conformation
(Supplementary Figure 2). However, the functional integrity of the
purified chimaera remains to be determined.
In summary, our study demonstrated that the transmembrane
region harbouring the key functional elements of hERG can be sub-
stituted into Kv1.2 to generate chimaeras that were able to recapitu-
late almost all of the properties of hERG. Thus Kv1.2 could provide a
perfect framework for functional substitution of distantly related Kv
and other 6-TM channels. Since Kv1.2 is also one of the eukaryotic
6-TMproteins that could exceptionally be overexpressed and crystal-
lised, the present study presents a promising strategy for overpro-
duction of other 6-TM channels that are difficult to overexpress and
crystallise.
Experimental procedures
Materials. pPIC3.5-rat Kv1.2 containing the His9 tag at the N-terminus7 and hERG
cDNA in pSP64 were kindly provided Dr. D. Parcej and Prof. S.A. Goldstein
respectively. KM71 Pichia pastoris cells were from Invitrogen. Enzymes formolecular
biology were purchased from New England Biolabs, Promega or Stratagene. All
general chemicals were obtained from Sigma Chemicals Co. Mouse anti-His tag, goat
anti-mouse HRP were purchased from Novagen and BioRad laboratories
respectively.
Methods
Preparation of DNA constructs.Overlap extension or substitution PCR was used to
generate the desired chimaeric constructs depicted in Fig. 2a. The constructs were
made fromHis9-Kv1.2 and hERG cDNA templates, such that all constructs contained
the N-terminal His9 tag. Three chimaeric constructs were generated using the Kv1.2
and hERG sequence alignment (based on the X-ray structure of Kv1.2 and structure-
function studies of hERG) as a guide (Fig. 1). The chimaeras have the following amino
acid sequences (hERG in bold; the numbers correspond to the primary sequences of
rat Kv1.2 (GI:1235594) and hERG (GI:60391379).
P-S6 1–363/614–667/412–499
S4/S5–S6 1–328/539–675/425–499
S1–S6 1–164/395–675/426–499
The chimaeras were subcloned into the pKS-Globin (Kv1.2, P-S6 and S4/5-S6
constructs) or pBF (hERG and S1–S6) oocyte expression vectors for electrophysio-
logical studies in Xenopus oocytes or pPIC3.5 for overexpression in Pichia pastoris.
All constructs were fully sequenced to confirm the identity.
Preparation of cRNA and current recordings. cRNA was prepared using the T7/
SP6 mMessage machine synthesis kit (Ambion). cRNA was injected into the stage
V or VI oocytes, isolated from Xenopus toads (euthanised by cervical dislocation
after anaesthetization with MS-222) as described previously11. Injected oocytes
were incubated in ND96 solution (NaCl 96 mM, KCl 2 mM, MgCl2 1 mM,
HEPES 5 mM, CaCl2 1.8 mM, pH 7.5, 50 mg/ml G418) at 18uC, for 1–3 days,
prior to current recordings. Currents were recorded from oocytes by two-electrode
voltage clamp. The recording chamber was perfused with Ringer’s extracellular
solution (NaCl 115 mM, KCl 2.5 mM, CaCl2 1.8 mM, HEPES 10 mM, pH 7.2) at
a rate of ,1 ml/min. Voltage clamp was established with two thin-walled
borosilicate glass (GC100F-15, Harvard Apparatus Ltd) microelectrodes filled with
3 M KCl that had a resistance of 0.5 to 5 MV. Membrane potential was controlled
using a GeneClamp 500 amplifier (Molecular Devices), digitised using a NI USB-
6211 (National Instruments) and recorded using WinWCP (V 4.0.5) software.
Recordings were filtered at 2 kHz and sampled at 4 kHz. A holding potential of
280 mV was used unless otherwise stated. Protocols used varied depending on
the objective of the experiment (see figures).
Currents were elicited by pulsing to various test potentials (280 mV to
140 mV) for 1 s from a holding potential of 280 mV (Fig. 2c) before stepping to
250 mV (1 s). Currents at the end of the test pulse (steady-state) and at the
beginning of the 250 mV step (tail current) were plotted against the test poten-
tials. Activation time constants were determined from the rising phase of currents
for each test potential. To determine voltage dependence of fully activated chan-
nels, a 140 mV pulse (1 s) was delivered from a holding potential of 280 mV
before stepping to various test potentials (2120 to 150 mV) (Fig. 4a). Currents at
the beginning of each test potential were plotted against voltage. Deactivation time
constants were determined from the decay of currents at each test potential. To
determine recovery from steady-state inactivation, a three pulse voltage protocol
was used (Fig. 5a). The first 135 mV pulse (1 s) was delivered from a holding
voltage of 280 mV to fully inactivate the channels; the second pulse to various test
potentials in 10 mV increments (2145 mV to 135 mV) was brief (20 ms) to
allow voltage dependent recovery from inactivation; and the third pulse was to
135 mV for 20 s, which allowed measurement of currents recovered during the
second pulse. Peak currents during the third pulse were plotted against voltage to
determine the voltage dependence of recovery from steady-state inactivation. All
data are collected from n $ 3.
Electrophysiological data analysis. Raw data were analysed using Clampfit 9.2
(Molecular Devices) and then compiled in Excel 2007 (Microsoft) and OriginPro 7.5
(Originlab). Mean and SEM values were calculated for current recordings and the
non-paired two-tailed Students T-test was used to determine statistical significance
where appropriate. Tail currents and recovery from steady state inactivation currents
were fitted with unconstrained Boltzmann function (equation 1).
G~
Gmax{G0
1ze
V{V1
2
 
k
zG0 ð1Þ
Where G0 is the initial conductance, V1/2 is the half-activation voltage and k is a
measure of the voltage dependence.
Activation time courses were fitted in WinWCP software with a two exponential
equation (equation 2).
It~Afast| exp t=tfastð ÞzAslow| exp t=tslowð Þ ð2Þ
where tfast and tslow are the time constants for the fast and slow components of
activation, and Afast and Aslow are the current amplitudes of each component.
Deactivation time courses were fitted in WinWCP software with two decaying
exponentials (equation 3).
Itail tð Þ~Afast| exp {t=tfastð ÞzAslow| exp {t=tslowð ÞzC ð3Þ
where tfast and tslow are the time constants for the fast and slow components of
deactivation, Afast and Aslow are the current amplitudes of each component, and C is a
constant.
Percentage inhibition of current by dofetilide (I%) was calculated by normalisation
of current in the presence of the drug (I) to current in the presence of vehicle (I[B]0)
(equation 4)
I%~
I
I B½ 0
 
 100 ð4Þ
Data from dose dependent drug inhibition of currents were fitted individually to the
normalised data for each oocyte with maxima asymptoted to 100% with equation 5.
I~
I B½ 0
1z B½ IC50
 H  ð5Þ
where H is the Hill coefficient, [B] is inhibitor concentration and I[B]0 is the current
in the absence of inhibitor. IC50 values were collated and averaged (6SEM) to
determine final IC50 values for each construct.
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Expression and purification of the S1–S6 chimaera. Transformation of P. pastoris
KM71, cell culture and methanol induction of protein expression were carried out as
described previously7. Colonies resistant to 1 mg/ml G418 were used for protein
expression. Cells were grown in 2 l flaks to sufficient density in MGYH (1.34% yeast
nitrogen base, 1% glycerol, 0.00004% biotin, 0.004% histidine) medium at 27uC in a
shaking incubator (200 r.p.m.) Protein expression was induced by replacing the
MGYH medium with MMH (1.34% yeast nitrogen base, 0.5% methanol, 0.00004%
biotin, 0.004% histidine) medium and growing cells for 3 days at 27uC in a shaking
incubator at 200 r.p.m. 0.5% methanol was supplemented every 24 hr. Cells were
harvested by centrifugation and the pellets were suspended in lysis buffer (50 mM
phosphate buffer, pH 8.0, 5% (v/v) glycerol, 1 mM EDTA, 34 mg/ml PMSF, 13
EDTA-free protease inhibitor cocktail (Roche)). The suspension was homogenised
with 0.5 mm acid washed glass beads in a BeadBeater (BioSpec Products: Bartlesville,
USA), following the instructions of the manufacturer. Unbroken cells and glass beads
were collected by centrifugation at 4000 g. The supernatant was then centrifuged at
100000 3 g to pellet the membrane fraction. The membrane pellet was washed by
resuspending in lysis buffer and re-centrifugation at 100000 3 g.
Membranes (50–100 mg) were solubilised in 1% NP-40, 50 mM Tris, 150 mM
KCl, 10 mM 2-mercaptoethanol, pH 7.5 at room temperature for 3 hr, using a
rotating mixer (detergent to protein ratio was kept at 551). The suspension was
centrifuged at 100,0003 g for 1 hr to remove insolublematerial. The supernatant was
loaded onto TalonH metal affinity resin (Clontech) equilibrated with equilibration
buffer (0.5% NP-40, 50 mM Tris, 150 mM KCl, 10 mM 2-mercaptoethanol, 20 mM
imidazole, pH 7.5). After washing with the equilibration buffer and a high salt wash
buffer (1 MNaCl in equilibration buffer), the bound protein was eluted with 500 mM
imidazole made up in the equilibration buffer. Aliquots of each fraction were sub-
jected to SDS-PAGE and stained with Coomassie Brilliant Blue.
Western blotting. Expression of the S1–S6 chimaera in Pichiawas detected by western
blotting using anti-His-tag antibody (1520000), goat anti-mouse-HRP conjugated
IgG (1540000), and SuperSignal West Femto Maximum Sensitivity ECL Substrate
(Pierce).
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